About
Technology
Issues
FAQ
Links
Official Page
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.